REPH Historical PE Ratio image   This REPH PE ratio history page last updated 3/2/2022
REPH PE History Chart
PeriodPriceGAAPTTMPE
Q4 2021
3/1/2022
1.68-0.04-0.31NA
Q3 2021
11/9/2021
1.88-0.07-0.75NA
Q2 2021
8/9/2021
1.960.03-0.77NA
Q1 2021
5/6/2021
2.51-0.23-1.05NA
Q4 2020
2/26/2021
3.43-0.48-1.15NA
Q3 2020
11/9/2020
1.98-0.09-1.05NA
Q2 2020
8/10/2020
3.34-0.25-1.13NA
Q1 2020
5/11/2020
5.08-0.33-1.00NA
Q4 2019
3/4/2020
11.00-0.38-0.76NA
Q3 2019
11/8/2019
15.65-0.17-0.90NA
Q2 2019
8/8/2019
9.75-0.12-1.30NA
Q1 2019
5/10/2019
8.16-0.09-1.74NA
Q4 2018
2/19/2019
7.78-0.52-2.23NA
Q3 2018
11/7/2018
6.54-0.57-2.85NA
Q2 2018
8/7/2018
5.08-0.56-2.71NA
Q1 2018
5/9/2018
9.84-0.58-2.58NA
Q4 2017
2/27/2018
8.00-1.14-2.38NA
Q3 2017
11/9/2017
7.84-0.43-1.97NA
Q2 2017
8/10/2017
6.55-0.43-1.99NA
Q1 2017
5/11/2017
6.83-0.38-2.30NA
Q4 2016
3/6/2017
6.82-0.73-2.56NA
Q3 2016
11/10/2016
6.74-0.45-2.47NA
Q2 2016
8/11/2016
8.02-0.74-2.24NA
Q1 2016
5/12/2016
5.97-0.64-1.65NA
Q4 2015
3/24/2016
5.32-0.64-1.49NA
Q3 2015
11/13/2015
8.42-0.22-1.25NA
Q2 2015
8/14/2015
12.42-0.15-1.58NA
Q1 2015
5/12/2015
8.57-0.48-1.75NA
Q4 2014
3/25/2015
8.43-0.40-4.56NA
Q3 2014
11/10/2014
2.69-0.55NANA
Q2 2014
8/12/2014
5.20-0.32NANA
Q1 2014
5/12/2014
5.66-3.29NANA
REPH Historical PE Ratio Chart
Data adjusted for REPH split history

PeriodPriceGAAPAnnualizedPE
Q4 2021
3/1/2022
1.68-0.04-0.16NA
Q3 2021
11/9/2021
1.88-0.07-0.28NA
Q2 2021
8/9/2021
1.960.030.1216.3
Q1 2021
5/6/2021
2.51-0.23-0.92NA
Q4 2020
2/26/2021
3.43-0.48-1.92NA
Q3 2020
11/9/2020
1.98-0.09-0.36NA
Q2 2020
8/10/2020
3.34-0.25-1.00NA
Q1 2020
5/11/2020
5.08-0.33-1.32NA
Q4 2019
3/4/2020
11.00-0.38-1.52NA
Q3 2019
11/8/2019
15.65-0.17-0.68NA
Q2 2019
8/8/2019
9.75-0.12-0.48NA
Q1 2019
5/10/2019
8.16-0.09-0.36NA
Q4 2018
2/19/2019
7.78-0.52-2.08NA
Q3 2018
11/7/2018
6.54-0.57-2.28NA
Q2 2018
8/7/2018
5.08-0.56-2.24NA
Q1 2018
5/9/2018
9.84-0.58-2.32NA
Q4 2017
2/27/2018
8.00-1.14-4.56NA
Q3 2017
11/9/2017
7.84-0.43-1.72NA
Q2 2017
8/10/2017
6.55-0.43-1.72NA
Q1 2017
5/11/2017
6.83-0.38-1.52NA
Q4 2016
3/6/2017
6.82-0.73-2.92NA
Q3 2016
11/10/2016
6.74-0.45-1.80NA
Q2 2016
8/11/2016
8.02-0.74-2.96NA
Q1 2016
5/12/2016
5.97-0.64-2.56NA
Q4 2015
3/24/2016
5.32-0.64-2.56NA
Q3 2015
11/13/2015
8.42-0.22-0.88NA
Q2 2015
8/14/2015
12.42-0.15-0.60NA
Q1 2015
5/12/2015
8.57-0.48-1.92NA
Q4 2014
3/25/2015
8.43-0.40-1.60NA
Q3 2014
11/10/2014
2.69-0.55-2.20NA
Q2 2014
8/12/2014
5.20-0.32-1.28NA
Q1 2014
5/12/2014
5.66-3.29-13.16NA
Quotes delayed 20 minutes

Email EnvelopeFree REPH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Recro Pharma (REPH) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

REPL PE Ratio History
RETA PE Ratio History
RGEN PE Ratio History
RGLS PE Ratio History
RGNX PE Ratio History
RIGL PE Ratio History
RLAY PE Ratio History
RLMD PE Ratio History
RLYB PE Ratio History
RMD PE Ratio History
On this page we presented the REPH PE Ratio History information for Recro Pharma' stock. The average REPH PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 16.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average REPH PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this REPH PE ratio history result, against the recent PE: when this page was posted on 3/1/2022, the most recent closing price for REPH had been 1.68, and the most recent quarterly earnings result, annualized, was 0.12. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent REPH PE on 3/1/2022 based on annualized quarterly EPS was 14.0. Based on REPH's history, that recent PE is low relative to the historical average, with the recent PE 14.1% lower than the historical average PE across our data set for Recro Pharma.

For self directed investors doing their due diligence on REPH or any other given stock, valuation analysis for REPH can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Recro Pharma PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for REPH. Thanks for visiting, and the next time you need to research REPH PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: NHTC Options Chain, PRSC Stock Predictions, Top Ten Hedge Funds Holding LOGO.

 

REPH PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.